Inventor · disambiguated record
Maria Oksana Bachynsky
Also filed as: BACHYNSKY MARIA O · BACHYNSKY MARIA OKSANA
6 granted patents·6 pending applications·143 citations·filing 1989–2018
83Inventor score
Top patents by PatentIndex Score
12 records- 0184US5190748AAbsorption enhancement of antibioticsHOFFMANN LA ROCHE·Filed 1991·Granted Mar 2, 1993·83 cites·21 claims
- 0275US4999375APsoralen reagent compositions for extracorporeal treatment of bloodHOFFMANN LA ROCHE·Filed 1989·Granted Mar 12, 1991·47 cites·31 claims
- 0373US11185588B2Pharmaceutical dosage forms comprising valganciclovir hydrochlorideHOFFMANN LA ROCHE·Filed 2018·Granted Nov 30, 2021·0 cites·1 claims
- 0473US8889109B2Pharmaceutical dosage forms comprising valganciclovir hydrochlorideHOFFMANN LA ROCHE·Filed 2013·Granted Nov 18, 2014·1 cites·1 claims
- 0565US9642911B2Pharmaceutical dosage forms comprising valganciclovir hydrochlorideHOFFMANN LA ROCHE·Filed 2014·Granted May 9, 2017·0 cites·1 claims
- 0663US2018153998A1Novel pharmaceutical dosage forms comprising valganciclovir hydrochlorideHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0763US2008146591A1Novel pharmaceutical dosage forms comprising valganciclovir hydrochlorideBACHYNSKY MARIA OKSANA·Filed 2007·Application pending·0 cites
- 0860US2017266286A1Novel pharmaceutical dosage forms comprising valganciclovir hydrochlorideHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0954US2008085310A1Capecitabine rapidly disintegrating tabletsBACHYNSKY MARIA OKSANA·Filed 2007·Application pending·0 cites
- 1053US2015044287A1Capecitabine rapidly disintegrating tabletsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1152US2011027374A1Capecitabine rapidly disintegrating tabletsBACHYNSKY MARIA OKSANA·Filed 2009·Application pending·0 cites
- 1246US5036102AMethod of treating autoimmune diseases comprising administration of psoralen dosage formsHOFFMANN LA ROCHE·Filed 1990·Granted Jul 30, 1991·12 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Maria Oksana Bachynsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →